Andrew Aronsohn, MD

Andrew Aronsohn is an Associate Professor of Medicine in the Center for Liver Diseases at the University of Chicago Medical Center. Dr. Aronsohn is also a faculty member at the MacLean Center for Clinical Medical Ethics at the University of Chicago.  Dr. Aronsohn is the co-principal investigator of HepCCATT, a CDC funded initiative to diagnose, link to care and treat HCV in the Chicago area. This project utilizes telehealth technology to expand HCV management into the primary care setting.  Dr. Aronsohn is the co-lead of the treatment experienced section of the AASLD / IDSA HCV guidance writing committee as was a member of National Academies of Medicine committee which wrote “A National Strategy for the Elimination of Hepatitis B and C”.  He also has a busy clinical practice, which includes both general and transplant hepatology.